| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.256 | 11.003 | 11.676 | 15.309 | 12.309 | 13.527 | 31.197 | 34.308 | 38.661 | 60.187 |
| Total Income - EUR | 14.261 | 11.038 | 11.710 | 15.322 | 17.283 | 14.253 | 31.204 | 34.331 | 38.681 | 60.194 |
| Total Expenses - EUR | 19.364 | 18.808 | 16.689 | 14.277 | 23.785 | 18.552 | 20.204 | 25.027 | 23.092 | 59.382 |
| Gross Profit/Loss - EUR | -5.103 | -7.770 | -4.979 | 1.045 | -6.503 | -4.298 | 11.000 | 9.304 | 15.589 | 811 |
| Net Profit/Loss - EUR | -5.531 | -7.880 | -5.096 | 892 | -6.639 | -4.412 | 10.817 | 8.982 | 15.210 | 49 |
| Employees | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 0 | 0 | 2 |
Check the financial reports for the company - Ritavet Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1.426 | 869 | 307 | 0 |
| Current Assets | 20.061 | 20.202 | 22.042 | 25.223 | 11.274 | 14.339 | 25.526 | 36.882 | 18.505 | 24.620 |
| Inventories | 143 | 141 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.393 |
| Receivables | 13.801 | 15.257 | 15.644 | 18.064 | 4.287 | 7.079 | 5.306 | 3.190 | 5.193 | 7.368 |
| Cash | 6.117 | 4.804 | 6.398 | 7.159 | 6.987 | 7.260 | 20.220 | 33.692 | 13.312 | 6.858 |
| Shareholders Funds | 4.484 | -3.442 | -8.480 | -7.437 | -13.931 | -18.079 | -6.860 | 2.101 | 17.236 | 17.188 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.577 | 23.645 | 30.522 | 32.660 | 25.205 | 32.418 | 33.812 | 35.650 | 1.576 | 7.432 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Ritavet Medica Srl